<DOC>
	<DOCNO>NCT01242696</DOCNO>
	<brief_summary>The goal TAXUS™ Element™ Paclitaxel-Eluting Coronary Stent System European Post-Approval Surveillance Study evaluate real world clinical outcome data TAXUS™ Element™ Coronary Stent System unselected patient routine clinical practice .</brief_summary>
	<brief_title>TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System European Post-Approval Surveillance Study ( TE-Prove )</brief_title>
	<detailed_description>A prospective , open label , multi-center observational study all-comers enrollment approach approximately 1000 subject 50 site Europe .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<criteria>According Instructions For Use Contraindications accord Instructions Use</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Drug Eluting Stents</keyword>
	<keyword>Observational</keyword>
	<keyword>All-Comers</keyword>
</DOC>